Advertisement
Advertisement
TEVA
Teva Pharmaceutical Industries Limited
42.14
USDSponsored
-0.48
-1.12%
Nov 18, 15:22 UTC -5
Open
Teva Pharmaceutical Industries Limited (TEVA) Earnings
TEVA Earnings Reports
Positive Surprise Ratio
TEVA beat 16 of 32 last estimates.
50%
Next Report
Date of Next Report
Jan 26, 2027
Estimate for Q4 26 (Revenue/ EPS)
$4.34B
/$0.68
Implied change from Q3 26 (Revenue/ EPS)
-1.17%
/-20.93%
Implied change from Q4 25 (Revenue/ EPS)
-7.80%
/-29.17%
Teva Pharmaceutical Industries Limited earnings per share and revenue
On Nov 03, 2026, TEVA reported earnings of 0.86 USD per share (EPS) for Q3 26, beating the estimate of 0.74 USD, resulting in a 15.50% surprise. Revenue reached 4.39 billion, compared to an expected 4.38 billion, with a 0.42% difference. The market reacted with a +2.97% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of 0.68 USD, with revenue projected to reach 4.34 billion USD, implying an decrease of -20.93% EPS, and decrease of -1.17% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Personalis, Inc. Common Stock
Report Date
Nov 04, 2026 For Q3 26
Estimate
-$0.25
Actual
-$0.32
Surprise
-24.08%

Taysha Gene Therapies, Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.13
Actual
-$0.10
Surprise
+24.59%

Amphastar Pharmaceuticals, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.87
Actual
$1.13
Surprise
+30.18%

Assembly Biosciences, Inc
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.45
Actual
-$0.93
Surprise
-104.89%

Sol-Gel Technologies Ltd. Ordinary Shares
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$2.11
Actual
-$1.72
Surprise
+18.67%

Metagenomi Therapeutics, Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.64
Actual
-$0.56
Surprise
+13.31%
FAQ
What were Teva Pharmaceutical Industries Limited's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Teva Pharmaceutical Industries Limited reported EPS of $0.86, beating estimates by 15.5%, and revenue of $4.39B, 0.42% above expectations.
How did the market react to Teva Pharmaceutical Industries Limited's Q3 2026 earnings?
The stock price moved up 2.97%, changed from $40.70 before the earnings release to $41.91 the day after.
When is Teva Pharmaceutical Industries Limited expected to report next?
The next earning report is scheduled for Jan 26, 2027.
What are the forecasts for Teva Pharmaceutical Industries Limited's next earnings report?
Based on --
analysts, Teva Pharmaceutical Industries Limited is expected to report EPS of $0.68 and revenue of $4.34B for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.